Toward Global No.1
in Pain Management.
Red & Blue researches personalized pain solutions on a foundation of bioelectrical data analysis. Trigger-point detection and visualization, pain-severity software, and pain-therapy medical devices — we connect every stage of pain management.
A 30-year clinician's company, built to make pain visible through data.
After three decades of treating pain patients, one question stayed with me: what if we could see pain objectively, before ordering an X-ray or MRI? Red & Blue Co., Ltd. was founded to answer that question.
Through PAIN BOT — a device that makes trigger points visible — and our pain-measurement software, we have moved pain diagnosis from subjective complaint onto data. The same device then continues into ultrasound and low-frequency therapy.
Standing on a customer-, user-, and patient-first principle, we commit to the promise of 'For Health Value, For Better Life.' Beyond Korea, we will be remembered across Southeast and Central Asia as 'the company that makes pain visible.'
- CEO, Red & Blue Co., Ltd.
- Hospital Director, Yesan Myeongji Hospital
- Honorary Chairman, Korea Balance Medical Association
- Honorary Board Chair, International Medical Volunteer Foundation
- Publisher & Editor, Medical Focus
- Organizing Chairman, IVRA (International Virus Research Alliance)
- Soonchunhyang University, College & Graduate School of Medicine
Technology, clinic, and network — three engines at once.
World-first pain visualization, a CEO with 30 years of clinical practice, and a network of 1,800 physicians. The three locking together puts us where competitors cannot easily follow.
World-first pain visualization
Trigger points are color-coded by electrical-impedance differences. PAIN BOT integrates diagnosis and therapy in a single device.
30-year pain-clinic CEO
A hospital director and honorary chairman of the Korea Balance Medical Association designs the products and leads physician training in person.
1,800-physician network
Education, marketing, and overseas-sales channels via the Korea Balance Medical Association, Medical Focus, the International Medical Volunteer Foundation, and IVRA.
SCI paper + 5 country approvals
Clinical validation in MDPI-Diagnostics (2024) and MDA approvals across five Southeast Asian and Central Asian markets.
The path we have walked
Since our founding in 2017, we have built up R&D and manufacturing, secured medical-device approvals, expanded into five overseas markets, and published in an SCI journal.
- 201709Red & Blue Co., Ltd. established
- 201807Corporate R&D center established
- 201910Godeok factory built (Yesan, Korea)
- 202010Medical-device GMP conformity
- 11ISO 13485:2016 certification
- 12PAIN BOT (PB101) — medical-device approval
- 202104BIO BALANCE GUN (BBG101) — medical-device approval
- 202204Pain Measurement Software released
- 12Malaysia export contract signed
- 202306Soonchunhyang University IRB clinical study approved
- 07Malaysia MDA — PAIN BOT approved
- 202405Indonesia MDA — PAIN BOT approved
- 10Singapore HSA — PAIN BOT approved
- 11Published in MDPI-Diagnostics (SCI): sensitivity & specificity above 95%
- 202506Philippines FDA — PAIN BOT approved
- 08Kyrgyzstan — PAIN BOT approved
Medical-device approvals in 5 countries.
After Korean MFDS approval, PAIN BOT has been cleared in four Southeast Asian countries and one Central Asian country. Thailand approval is in progress, with additional ASEAN markets being prepared.
- MY2023.07MalaysiaMDA
- ID2024.05IndonesiaMDA
- SG2024.10SingaporeHSA
- PH2025.06PhilippinesFDA
- KG2025.08KyrgyzstanMoH
- THIn progressThailandFDA
We move on a 1,800-physician network.
We directly run four organizations — covering education, marketing, social value, and overseas sales — so we do more than sell devices; we co-design the pain-clinic model itself.
- EDUCATION & SALES
Korea Balance Medical Association
A professional society for non-surgical pain therapy with more than 1,800 physician members. Its founder and honorary chairman is Red & Blue's CEO.
- MARKETING
Medical Focus
A specialized health & medical online newspaper published directly by physicians. Used as our medical-community marketing channel.
- SOCIAL VALUE
International Medical Volunteer Foundation
A physician-led medical volunteer organization active at home and abroad — anchoring our social value and trust.
- GLOBAL SALES
IVRA
International Virus Research Alliance — a global research consortium that doubles as our access point to overseas conferences and buyers.
Quality, technology, and clinic — proven on paper.
Quality system, registered patents and designs, SCI-level clinical paper, and MDA approvals in five overseas markets — our technology and products are verified on four fronts.
- GMP
- Medical-device manufacturing & quality-control (GMP) conformity
- ISO
- ISO 13485:2016 medical-device quality management system
- VENTURE
- Venture-business confirmation (innovation type) · Corporate R&D center recognition
- IP
- Multiple registered patents (anti-rotation accessory KR 10-2487876, etc.), registered designs, and trademark applications
- PAPER
- MDPI-Diagnostics (SCI, Nov 2024) — diagnostic sensitivity & specificity above 95%
- GLOBAL
- MDA medical-device approvals in 5 countries (Malaysia, Indonesia, Singapore, Philippines, Kyrgyzstan)
Anything else you would like to know?
Product specifications, clinical materials, overseas distributorship — whatever you need, our team will guide you quickly.